Comparison of discharge pharmacological treatments for UK, European, and multinational groups of patients by baseline condition
| ST elevation MI | p Value | Non-ST elevation MI | p Value | Unstable angina | p Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UK (n = 390) | Eur (n = 2729) | MN (n = 3696) | UK v Eur | UK v MN | UK (n = 376) | Eur (n = 1602) | MN (n = 4111) | UK v Eur | UK v MN | UK (n = 605) | Eur (n = 2174) | MN (n = 4457) | UK v Eur | UK v MN | |
| Aspirin | 94% | 90% | 92% | 0.0218 | 0.2176 | 92% | 86% | 88% | 0.0015 | 0.0146 | 92% | 86% | 87% | 0.0005 | 0.0042 |
| Thienopyridine | 14% | 47% | 40% | <0.0001 | <0.0001 | 28% | 41% | 30% | <0.0001 | 0.5241 | 23% | 28% | 23% | 0.0381 | 0.8314 |
| β Blocker | 76% | 73% | 78% | 0.2673 | 0.3280 | 72% | 70% | 74% | 0.4998 | 0.3611 | 70% | 64% | 71% | 0.0038 | 0.6630 |
| Ca2+ blocker | 12% | 9% | 11% | 0.0037 | 0.4176 | 31% | 20% | 21% | <0.0001 | <0.0001 | 49% | 36% | 32% | <0.0001 | <0.0001 |
| ACEI | 51% | 64% | 70% | <0.0001 | <0.0001 | 44% | 56% | 51% | <0.0001 | 0.0109 | 33% | 54% | 47% | <0.0001 | <0.0001 |
| Statin | 75% | 49% | 46% | <0.0001 | <0.0001 | 68% | 55% | 48% | <0.0001 | <0.0001 | 65% | 52% | 34% | 0.4799 | <0.0001 |